전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved55 programs
AntibodyLimited DatastaleAbbottPhase 3

adalimumab (Humira, Open-labelAdalimumabRescue)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Abbott
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

rituximab (Rituxan, Originator rituximab - Rituxan ® or MabThera ®)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastalePfizerPhase 2

tanezumab (PF-04383119, PF-04383119 (tanezumab))

Osteoarthritis, Knee · Osteoarthritis, Knee

#OsteoarthritisKnee#Antibody#Phase2#monoclonal-antibody#Osteoarthritis+2
Trials 1Status Active
AntibodyLimited DatastaleSamsung Bioepis Co., Ltd.Phase 3

proposed biosimilar to infliximab (SB2, SB2 (proposed biosimilar to infliximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Samsung
Trials 1Status Active
AntibodyLimited DatastaleAbbViePhase 3

proposed biosimilar to adalimumab (SB5, SB5 (proposed biosimilar to adalimumab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 1Status Active
AntibodyLimited DatastaleMoonLake Immunotherapeutics AGPhase 2

Sonelokimab (Sonelokimab)

Arthritis, Psoriatic · Arthritis, Psoriatic

#ArthritisPsoriatic#Antibody#Phase2#monoclonal-antibody#Arthritis+2
Trials 1Status Active
AntibodyLimited DatastaleAbbVieApproved

infliximab, adalimumab, etanercept (TNF blockers, TNF blockers (infliximab, adalimumab, etanercept))

Arthritis, Rheumatoid; Spondylitis, Ankylosing · Arthritis, Rheumatoid

#ArthritisRheumatoid#Antibody#Approved#monoclonal-antibody#Arthritis+3
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

Actemra® (Tocilizumab, Tocilizumab (Actemra®))

Rheumatoid Arthritis; Inflammation · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#monoclonal-antibody#Inflammation+1
Trials 1Status Active
AntibodyLimited DatastaleJanssenApproved

Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Active
AntibodyLimited DatastaleAbbViePreclinical

etanercept, infliximab, adalimumab, and golimumab (Tumor Necrosis Factor Inhibitor, Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab))

Infection; Rheumatoid Arthritis · Infection

#Infection#Antibody#Preclinical#monoclonal-antibody#RheumatoidArthritis+1
Trials 1Status Active
AntibodyLimited DatastaleUniversity Hospital, Strasbourg…Approved

abatacept, rituximab or tocilizumab (abatacept, rituximab or tocilizumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Active
AntibodyLimited DatastaleImperial College LondonPreclinical

etanercept or adalimumab (anti-TNF therapy, anti-TNF therapy (etanercept or adalimumab))

Rheumatoid Arthritis; Ankylosing Spondylitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#monoclonal-antibody#AnkylosingSpondylitis+1
Trials 1Status Active
AntibodyLimited DatastaleMedical University of GrazApproved

etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept (bDMARD withdrawal, bDMARD withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#Medical
Trials 1Status Discontinued
AntibodyLimited DatastaleJanssenPreclinical

response to infliximab associated with methotrexate (response to infliximab associated with methotrexate)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#monoclonal-antibody#Janssen
Trials 1Status Active
AntibodyLimited DatastaleRocheApproved

tocilizumab [RoActemra/Actemra] (tocilizumab [RoActemra/Actemra])

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#Roche
Trials 1Status Discontinued

3 / 3 pages

← PreviousNext →